Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology).
Scoccianti S, Magrini SM, Ricardi U, Detti B, Buglione M, Sotti G, Krengli M, Maluta S, Parisi S, Bertoni F, Mantovani C, Tombolini V, De Renzis C, Lioce M, Fatigante L, Fusco V, Muto P, Berti F, Rubino G, Cipressi S, Fariselli L, Lupattelli M, Santoni R, Pirtoli L, Biti G. Scoccianti S, et al. Among authors: fusco v. Neurosurgery. 2010 Aug;67(2):446-58. doi: 10.1227/01.NEU.0000371990.86656.E8. Neurosurgery. 2010. PMID: 20644432
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology).
Scoccianti S, Magrini SM, Ricardi U, Detti B, Krengli M, Parisi S, Bertoni F, Sotti G, Cipressi S, Tombolini V, Dall'oglio S, Lioce M, Saieva C, Buglione M, Mantovani C, Rubino G, Muto P, Fusco V, Fariselli L, de Renzis C, Masini L, Santoni R, Pirtoli L, Biti G. Scoccianti S, et al. Among authors: fusco v. Neuro Oncol. 2012 Jun;14(6):798-807. doi: 10.1093/neuonc/nos081. Epub 2012 Apr 25. Neuro Oncol. 2012. PMID: 22539339 Free PMC article.
Postoperative 5-FU based radiochemotherapy in rectal cancer: retrospective long term results and prognostic factors of a pooled analysis on 1,338 patients.
Genovesi D, Myerson RJ, Cèfaro GA, Vinciguerra A, Augurio A, Trignani M, DI Tommaso M, Nuzzo M, Lupattelli M, Aristei C, Bellavita R, Scandolaro L, Cosentino D, Pani G, Ziccarelli L, Gambacorta MA, Barba MC, Maranzano E, Trippa F, Sciacero P, Niespolo R, Leonardi C, Iannone T, Rosetto ME, Fusco V, Sanpaolo P, Melano A, Valvo F, Capirci C, DE Paoli A, DI Nicola M, Mantello G, Valentini V; G.I. A.I.R.O. Working Group. Genovesi D, et al. Among authors: fusco v. Anticancer Res. 2013 Oct;33(10):4557-66. Anticancer Res. 2013. PMID: 24123031
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey.
Macchia G, Sainato A, Talamini R, Boz G, Bacigalupo A, Caravatta L, Fiore M, Friso ML, Fusco V, Lupattelli M, Mantello G, Mattiucci GC, Slim N, Sciacero P, Turri L, Valentini V, Morganti AG, Genovesi D. Macchia G, et al. Among authors: fusco v. Oncol Rep. 2015 Jul;34(1):382-90. doi: 10.3892/or.2015.3955. Epub 2015 May 6. Oncol Rep. 2015. PMID: 25955190
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions.
Fellin G, Mirri MA, Santoro L, Jereczek-Fossa BA, Divan C, Mussari S, Ziglio F, La Face B, Barbera F, Buglione M, Bandera L, Ghedi B, Di Muzio NG, Losa A, Mangili P, Nava L, Chiarlone R, Ciscognetti N, Gastaldi E, Cattani F, Spoto R, Vavassori A, Giglioli FR, Guarneri A, Cerboneschi V, Mignogna M, Paoluzzi M, Ravaglia V, Chiumento C, Clemente S, Fusco V, Santini R, Stefanacci M, Mangiacotti FP, Martini M, Palloni T, Schinaia G, Lazzari G, Silvano G, Magrini S, Ricardi U, Santoni R, Orecchia R. Fellin G, et al. Among authors: fusco v. Br J Radiol. 2016 Sep;89(1065):20150981. doi: 10.1259/bjr.20150981. Epub 2016 Jul 7. Br J Radiol. 2016. PMID: 27384381 Free PMC article.
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO).
Scoccianti S, Krengli M, Marrazzo L, Magrini SM, Detti B, Fusco V, Pirtoli L, Doino D, Fiorentino A, Masini L, Greto D, Buglione M, Rubino G, Lonardi F, Migliaccio F, Marzano S, Santoni R, Ricardi U, Livi L. Scoccianti S, et al. Among authors: fusco v. Radiol Med. 2018 Jan;123(1):48-62. doi: 10.1007/s11547-017-0806-y. Epub 2017 Sep 6. Radiol Med. 2018. PMID: 28879459 Clinical Trial.
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial.
Pedretti S, Masini L, Turco E, Triggiani L, Krengli M, Meduri B, Pirtoli L, Borghetti P, Pegurri L, Riva N, Gatta R, Fusco V, Scoccianti S, Bruni A, Ricardi U, Santoni R, Magrini SM, Buglione M. Pedretti S, et al. Among authors: fusco v. J Neurooncol. 2019 Jul;143(3):447-455. doi: 10.1007/s11060-019-03175-2. Epub 2019 May 4. J Neurooncol. 2019. PMID: 31054101 Clinical Trial.
The role of palliative interventional radiotherapy (brachytherapy) in esophageal cancer: An AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic review focused on dysphagia-free survival.
Lancellotta V, Cellini F, Fionda B, De Sanctis V, Vidali C, Fusco V, Barbera F, Gambacorta MA, Corvò R, Magrini SM, Tagliaferri L. Lancellotta V, et al. Among authors: fusco v. Brachytherapy. 2020 Jan-Feb;19(1):104-110. doi: 10.1016/j.brachy.2019.09.005. Epub 2019 Oct 18. Brachytherapy. 2020. PMID: 31636025
222 results